文献速递肝胆胰外科胃肠外科

优化技术不可切除结直肠癌肝转移的筛选

Optimizing the selection of technically unresectable colorectal liver metastases.
PubMed 文献 · Surgery · 2022-11-13

本研究为单中心回顾性研究,分析2014-2021年892例连续患者,其中122例为技术不可切除结直肠癌肝转移,61例接受转化手术。转化手术组中位总生存期显著高于非转化组(5.6年 vs 1.8年,P < .001)。基于4个预测因素构建的转化手术预测模型AUC为0.889,按评分分组后转化率分别为91.5%(A组)、32.6%(B组)、10.3%(C组)。

要点

  • 转化手术可显著改善技术不可切除结直肠癌肝转移患者生存。
  • 预测模型基于RAS状态、肿瘤数目、肝静脉接触和可保留段。
  • 模型评分分组可区分转化概率和预后。

核心结论

  • 接受转化手术的技术不可切除结直肠癌肝转移患者预后更好。
  • 基于4个预测因素的新模型有助于预测转化手术和预后。

研究设计与样本

  • 单中心回顾性研究,纳入2014-2021年892例连续患者。
  • 122例为技术不可切除结直肠癌肝转移,其中61例接受转化手术,61例未接受。

主要发现

  • 转化手术组中位总生存期5.6年,非转化组1.8年,差异显著(P < .001)。
  • 预测模型AUC为0.889,评分A组(0-2分)转化率91.5%,B组(3-4分)32.6%,C组(5-6分)10.3%(P < .001)。
  • A组中位生存期5.7年,B组2.2年,C组1.6年,差异显著(P < .001)。

关键数值与推荐

  • 转化手术指征:化疗反应允许完整切除结直肠癌肝转移且切缘阴性、剩余肝体积充足。
  • 预测因素评分:RAS突变+2分,肿瘤数目≥15 +1分,接触≥2支肝静脉+1分,无可保留段+2分。

临床怎么用

  • 对于技术不可切除结直肠癌肝转移患者,可依据RAS状态、肿瘤数目、肝静脉接触和可保留段评估转化手术可能性。
  • 评分A组患者转化成功率高且预后好,B组和C组需更谨慎选择转化策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The prediction of conversion surgery in patients with technically unresectable colorectal liver metastases has not been generalized or well-established. We developed a predictive model for conversion surgery and assessed the long-term outcomes of patients with technically unresectable colorectal liver metastases. METHODS: In this single-center, retrospective study, we analyzed the perioperative parameters and outcomes of 892 consecutive patients (2014-2021). Conversion surgery was indicated when the chemotherapy response allowed the complete resection of colorectal liver metastases with negative margins and adequate remnant liver volume. RESULTS: Of the 892 patients, 122 had technically unresectable colorectal liver metastases; 61 underwent conversion surgery (conversion surgery group) and 61 did not (nonconversion surgery group). The median overall survival was significantly higher in the conversion surgery group than in the nonconversion surgery group (5.6 vs 1.8 years, P < .001). After univariate and multivariate analyses, the predictive model for conversion surgery was constructed using 4 predictive factors: Rat sarcoma viral oncogene homolog status (mutant, +2 points), tumor number (≥15, +1), hepatic vein contact (≥2 hepatic veins, +1), and the presence of preservable sections (absence of preservable sections, +2). The area under the curve for conversion surgery was 0.889. Patients were graded according to the scores (A [0-2], B [3-4], and C [5-6]), and the conversion rates were 91.5% (A), 32.6% (B), and 10.3% (C) (P < .001). Grade A patients (median survival time, 5.7 years) had significantly better overall survival than grade B and C patients (median survival time, 2.2 and 1.6 years, respectively; P < .001). CONCLUSION: Patients who underwent conversion surgery for technically unresectable colorectal liver metastases had better prognoses, and our novel predictive model was useful in predicting conversion surgery and prognosis.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Kobayashi K, Inoue Y, Kitano Y, et al. Optimizing the selection of technically unresectable colorectal liver metastases. Surgery. 2022. PMID: 36384649. doi:10.1016/j.surg.2022.10.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。